Sejong Medical Co., Ltd. (KOSDAQ:A258830) acquired 14.01% stake in Genencell Co., Ltd from Se-chan Kang for KRW 6.3 billion on October 19, 2021. Sejong Medical Co acquired 0.66 million shares of Genencell Co., Ltd in the deal. The full payment was made on October 19, 2021. The deal was funded with holding funds of Sejong Medical Co., Ltd. Genencell Co., Ltd had total assets of KRW 3.7 billion, net assets of KRW 2.5 billion, sales of KRW 150.58 million and net loss of KRW 1.8 billion million for the year ended December 31, 2020. The Board of Sejong Medical Co., Ltd. has resolved the deal on October 19, 2021.

Sejong Medical Co., Ltd. (KOSDAQ:A258830) completed the acquisition of 14.01% stake in Genencell Co., Ltd from Se-chan Kang on October 19, 2021.